CH

Clair Health

Builds technology for tracking women’s hormones, addressing health signals missed by mainstream wearables such as Oura and WHOOP.

AI Healthcare
Hormone Tracking
Total Raised
$12M
Last Valuation
$77M
Headquarters
San Francisco, CA
Share

Overview

Clair Health is developing a hormone-tracking product focused on women’s health, positioned against general-purpose wearables that may not capture hormone-driven signals. Its target market is women seeking more specific insight into hormonal patterns than products such as Oura or WHOOP provide. The company disclosed about $12 million in funding, including $11.6 million from Khosla Ventures in an undisclosed round. Led by Jenny Duan, Clair is differentiated by its narrow focus on women’s hormones rather than broad activity or recovery metrics.

Funding History

1 round · Jun 2026
$12M
Total Raised
1
Valuation: $77M
Cumulative: $12M

At 21, Jenny Duan saw what Oura and WHOOP missed: women’s hormones. She raised $11.6M from Khosla Ventures to track them

Investors not disclosed
Source

Frequently Asked Questions

How much has Clair Health raised in total?
Clair Health has raised a total of $12M across 1 funding round.
Who are Clair Health's investors?
Clair Health's investors include Undisclosed.
What does Clair Health do?
Clair Health is developing a hormone-tracking product focused on women’s health, positioned against general-purpose wearables that may not capture hormone-driven signals. Its target market is women seeking more specific insight into hormonal patterns than products such as Oura or WHOOP provide. The company disclosed about $12 million in funding, including $11.6 million from Khosla Ventures in an undisclosed round. Led by Jenny Duan, Clair is differentiated by its narrow focus on women’s hormones rather than broad activity or recovery metrics.
Where is Clair Health headquartered?
Clair Health is headquartered in San Francisco, CA.